| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/2010 | US20100087404 Method of treating and preventing hyperparathyroidism with active vitamin d analogs |
| 04/08/2010 | US20100087383 Intracerebral oxidation inhibitor and use thereof |
| 04/08/2010 | US20100087382 Inhibitors of Hepatitis C NS3 Protease |
| 04/08/2010 | US20100087381 Method of Stimulating the Motility of the Gastrointestinal System Using Growth Hormone Secretagogues |
| 04/08/2010 | US20100087380 Pharmaceutical compositions for inhibiting intestinal permeability |
| 04/08/2010 | US20100087379 Polypeptides of botryosphaeria rhodina |
| 04/08/2010 | US20100087378 Compositions and Methods for Treating Diseases Associate with Angiogenesis and Inflammation |
| 04/08/2010 | US20100087377 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; copper binding protein; inhibit the development of premalignant lesions in mammalian tissue |
| 04/08/2010 | US20100087376 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets |
| 04/08/2010 | US20100087375 Modulation of synaptogenesis |
| 04/08/2010 | US20100087374 Methods for Treatment and Diagnosis of Pulmonary Diseases Based on the Expression of SERCA2 Protein |
| 04/08/2010 | US20100087373 Detection and therapy of bacterial infection caused by enterobacteriaceae |
| 04/08/2010 | US20100087372 Growth hormone secretion stimulator |
| 04/08/2010 | US20100087371 Transglutaminase Variants with Improved Specificity |
| 04/08/2010 | US20100087370 Modulation of nitric oxide signaling to normalize tumor vasculature |
| 04/08/2010 | US20100087369 Composition comprising oligogalacturonans and polycationic saccharides |
| 04/08/2010 | US20100087368 Treating acute renal failure with soluble thrombomodulin variants |
| 04/08/2010 | US20100087367 Products and methods using soy peptides to lower total and ldl cholesterol levels |
| 04/08/2010 | US20100087366 Gh secretagogues and uses thereof |
| 04/08/2010 | US20100087365 Pharmaceutical Compositions of Hglp-1, Exendin-4 and Analogs Thereof |
| 04/08/2010 | US20100087364 Tropine modulators of 5-ht3 receptor |
| 04/08/2010 | US20100087363 Glycan modified soluble receptors and binding protein and their use |
| 04/08/2010 | US20100087362 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions |
| 04/08/2010 | US20100087361 Method to enhance hemodynamic stability using oxygen carrying compositions |
| 04/08/2010 | US20100087360 Heterocycle-substituted benzimidazole derivative |
| 04/08/2010 | US20100087359 Use of tryptophan rich peptides |
| 04/08/2010 | US20100087358 NOTCH mutations leading to increased receptor signaling |
| 04/08/2010 | US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 04/08/2010 | US20100086610 Vault and vault-like carrier molecules |
| 04/08/2010 | US20100086609 Methods and Compositions for Delivering Peptides |
| 04/08/2010 | US20100086608 Methods and Devices for Detecting Binding Events via Zeta-Potential and Pharmacologically Active Compounds and Delivery Systems Identified Thereby |
| 04/08/2010 | US20100086598 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/08/2010 | US20100086597 Microspheres for the sustained release of octreotide with a low initial burst |
| 04/08/2010 | US20100086596 Microspheres for releasing an octreotide compound without an initial time lag |
| 04/08/2010 | US20100086594 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 04/08/2010 | US20100086578 Fistula plug comprising ecm |
| 04/08/2010 | US20100086563 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) |
| 04/08/2010 | US20100086560 Chemokines as adjuvants of immune response |
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | US20100086558 isolated from Coprinus clastophyllus; for treating celiac disease caused by proline abundant gluten |
| 04/08/2010 | US20100086556 Use of hemagglutinin of the african swine fever virus as an adjuvant |
| 04/08/2010 | US20100086544 Compositions and methods for treating a neoplasm |
| 04/08/2010 | US20100086542 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists |
| 04/08/2010 | US20100086537 Polynucleotides and polypeptide sequences involved in cancer |
| 04/08/2010 | US20100086536 Method of Increasing Plasmin Activity through Antiplasmin Conversion |
| 04/08/2010 | US20100086533 Laglidadg homing endonuclease variants having novel substrate specificity and use thereof |
| 04/08/2010 | US20100086532 Chimeric zinc finger recombinases optimized for catalysis by directed evolution |
| 04/08/2010 | US20100086531 METHODS OF MODULATING PROTEIN HOMEOSTASIS, METABOLIC SYNDROME, HEAVY METAL INTOXICATION AND Nrf2 TRANSCRIPTION FACTORS |
| 04/08/2010 | US20100086529 Methods of making concentrated fibrinogen- and platelet-containing compositions |
| 04/08/2010 | US20100086525 Compositions and Methods for Altering Pancreas or Liver Function |
| 04/08/2010 | US20100086519 Treatment of Hepatitis C Infection With Metalloporphyrins |
| 04/08/2010 | US20100086518 Treatment of melanoma |
| 04/08/2010 | US20100086517 Enhancement of B cell proliferation by IL-15 |
| 04/08/2010 | US20100086516 Cytokine receptor chain |
| 04/08/2010 | US20100086515 Human il-4 muteins in cancer therapy |
| 04/08/2010 | US20100086501 Determining Age Ranges of Skin Samples |
| 04/08/2010 | US20100086486 Genetically modified human natural killer cell lines |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/08/2010 | DE10237317B4 Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung An enzyme-containing composition, to processes for their preparation and their use |
| 04/08/2010 | CA2740477A1 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut |
| 04/08/2010 | CA2739473A1 New hcv entry factor, occludin |
| 04/08/2010 | CA2739454A1 Methods for the treatment of graft-versus-host disease |
| 04/08/2010 | CA2739445A1 Site specific n-terminal modifications of proteins and conjugate formation |
| 04/08/2010 | CA2739418A1 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes |
| 04/08/2010 | CA2739387A1 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 04/08/2010 | CA2739384A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 04/08/2010 | CA2739357A1 Methods for predicting production of activating signals by cross-linked binding proteins |
| 04/08/2010 | CA2739180A1 Implantable device for the delivery of octreotide and methods of use thereof |
| 04/08/2010 | CA2739179A1 Implantable device for the delivery of histrelin and methods of use thereof |
| 04/08/2010 | CA2739178A1 Long term drug delivery devices with polyurethane-based polymers and their manufacture |
| 04/08/2010 | CA2739174A1 Treatment of biofilms |
| 04/08/2010 | CA2739083A1 Methods for suppressing toll-like receptor activity |
| 04/08/2010 | CA2739076A1 Methods of modulating the negative chemotaxis of immune cells |
| 04/08/2010 | CA2738993A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-releasing hormone (gnrh) as immunogen |
| 04/08/2010 | CA2738985A1 Therapeutic agent for hepatitis c |
| 04/08/2010 | CA2738930A1 Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors |
| 04/08/2010 | CA2738793A1 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens |
| 04/08/2010 | CA2738744A1 Peptide antagonist of interleukin-15 activity |
| 04/08/2010 | CA2738622A1 Compositions and methods for treatment of radiation exposure |
| 04/08/2010 | CA2738571A1 Production of products of pharmaceutical interest in plant cell cultures |
| 04/08/2010 | CA2738323A1 Treatment of mood and anxiety disorders |
| 04/07/2010 | EP2172552A2 Recombinant nucleic acids comprising regions of AD6 |
| 04/07/2010 | EP2172551A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/07/2010 | EP2172544A1 Novel adamts-13 mutant |
| 04/07/2010 | EP2172543A1 Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 04/07/2010 | EP2172539A1 Microorganism capable of producing gamma-L-PGA, method for production of Gamma-L-PGA using the microorganism, crosslinked product, and agent for external application to the skin |
| 04/07/2010 | EP2172486A2 Monoclonal antibody against a prion protein and its use for the detection of prions |
| 04/07/2010 | EP2172479A1 Glp-1 peptide having sugar chain attached thereto |
| 04/07/2010 | EP2172478A2 Activity-dependent neurotrophic factor III (ADNF III) |
| 04/07/2010 | EP2172476A2 Compositions and methods for WT1 specific immunotherapy |
| 04/07/2010 | EP2172474A1 Novel peptide and pharmaceutical use of the same |
| 04/07/2010 | EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 04/07/2010 | EP2172212A2 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 04/07/2010 | EP2172211A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| 04/07/2010 | EP2172210A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion |
| 04/07/2010 | EP2172209A1 Treatment of mood and anxiety disorders |
| 04/07/2010 | EP2172208A1 Small peptides for the treatment of Alzheimer's disease and other Beta-Amyloid protein fibrillogenesis disorders |
| 04/07/2010 | EP2172101A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 04/07/2010 | EP2171089A1 Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders |
| 04/07/2010 | EP2171062A1 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor |